نتایج جستجو برای: apoptosis memantine

تعداد نتایج: 157062  

2014
Victoria Omranifard Elham Shirzadi Saeid Samandari Hamid Afshar Mohammad Reza Maracy

BACKGROUND Proper management of depression in elderly population would improve the outcome of the disease and reduce its related disability and mortality. Use of memantine with minimal side effects and drug interaction seems reasonable in the elderly but its antidepressant activity is controversial. The aim of the current research is to investigate the effects of add-on memantine during citalop...

Journal: :Journal of neuroscience research 2008
Henrieta Scholtzova Youssef Z Wadghiri Moustafa Douadi Einar M Sigurdsson Yong-Sheng Li David Quartermain Pradeep Banerjee Thomas Wisniewski

Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been shown to improve learning and memory in several preclinical models of Alzheimer's disease (AD). Memantine has also been shown to reduce the levels of amyloid beta (A beta) peptides in human neuroblastoma cells as well as to inhibit A beta oligomer-induced synaptic loss. In this study, we assessed whether NMDA receptor inhib...

2017
Ruey Chen Pi-Tuan Chan Hsin Chu Yu-Cih Lin Pi-Chen Chang Chien-Yu Chen Kuei-Ru Chou

BACKGROUND This is the first meta-analysis to compare the treatment effects and safety of administering donepezil alone versus a combination of memantine and donepezil to treat patients with moderate to severe Alzheimer Disease, particularly regarding cognitive functions, behavioral and psychological symptoms in dementia (BPSD), and global functions. METHODS PubMed, Medline, Embase, PsycINFO,...

2013
Masahiko Takaya

INTRODUCTION Patients with idiopathic normal pressure hydrocephalus often show neuropsychiatric symptoms besides the triad of 'classic' symptoms. Memantine has been reported to have positive effects on the neuropsychiatric symptoms of patients with Alzheimer's disease and patients with dementia with Lewy bodies. We administered memantine to a Japanese patient with probable idiopathic normal pre...

2013
Marzia Martina Tanya Comas Geoffrey A. R. Mealing

The hippocampus is a complex network tightly regulated by interactions between excitatory and inhibitory neurons. In neurodegenerative disorders where cognitive functions such as learning and memory are impaired this excitation-inhibition balance may be altered. Interestingly, the uncompetitive N-methyl-d-aspartate receptor (NMDAR) antagonist memantine, currently in clinical use for the treatme...

2017
Martin Knapp Derek King Renée Romeo Jessica Adams Ashley Baldwin Clive Ballard Sube Banerjee Robert Barber Peter Bentham Richard G Brown Alistair Burns Tom Dening David Findlay Clive Holmes Tony Johnson Robert Jones Cornelius Katona James Lindesay Ajay Macharouthu Ian McKeith Rupert McShane John T O'Brien Patrick P J Phillips Bart Sheehan Robert Howard

OBJECTIVE Most investigations of pharmacotherapy for treating Alzheimer's disease focus on patients with mild-to-moderate symptoms, with little evidence to guide clinical decisions when symptoms become severe. We examined whether continuing donepezil, or commencing memantine, is cost-effective for community-dwelling, moderate-to-severe Alzheimer's disease patients. METHODS Cost-effectiveness ...

2015
Sheng-Yu Lee Shiou-Lan Chen Yun-Hsuan Chang Po See Chen San-Yuan Huang Nian-Sheng Tzeng Liang-Jen Wang I Hui Lee Tzu-Yun Wang Kao Chin Chen Yen Kuang Yang Jau-Shyong Hong Ru-Band Lu

Low-dose memantine might have anti-inflammatory and neurotrophic effects mechanistically remote from an NMDA receptor. We investigated whether add-on memantine reduced cytokine levels and benefitted patients with opioid dependence undergoing methadone maintenance therapy (MMT) in a randomized, double-blind, controlled 12-week study. Patients were randomly assigned to a group: Memantine (5 mg/da...

Journal: :Journal of substance abuse treatment 2014
Adam Bisaga Maria A Sullivan Andrew Glass Kaitlyn Mishlen Kenneth M Carpenter John J Mariani Frances R Levin Edward V Nunes

There is preclinical support for using NMDA receptor glutamatergic antagonists to aid in naltrexone-based treatment of opioid dependence. We hypothesized that adding memantine will improve efficacy of extended-release (XR) naltrexone to prevent relapse. In this double blind study opioid-dependent participants (N=82) underwent inpatient detoxification and naltrexone induction. During naltrexone ...

Journal: :Journal of cognitive neuroscience 2013
Benjamin Becker Eva M. Klein Nadine Striepens Yoan Mihov Thomas E. Schlaepfer Juergen Reul Liesbet Goossens Koen Schruers Keith M. Kendrick René Hurlemann

Hippocampal learning is thought to induce metaplasticity, which can facilitate subsequent learning. Administered at single low doses, the N-methyl-d-aspartate-type glutamate receptor antagonist memantine predominantly blocks α7 nicotinic acetylcholine receptors (α7 nAChRs). Placebo-controlled administration of a single low dose of memantine in a pharmaco-fMRI experiment may thus help characteri...

2013
Caroline Moreau Arnaud Delval Vincent Tiffreau Luc Defebvre Kathy Dujardin Alain Duhamel Gregory Petyt Claude Hossein-Foucher David Blum Bernard Sablonnière Susanna Schraen Delphine Allorge Alain Destée Régis Bordet David Devos

BACKGROUND Given that memantine is thought to decrease N-methyl-D-aspartic-acid-related (NMDA) glutamatergic hyperactivity and improve locomotion in rats, we sought to assess the drug's impact on axial symptoms in advanced Parkinson's disease (PD). METHODS We performed a 90-day, randomised, double-blind, study with two parallel arms: 20 mg/day memantine versus placebo (ClinicalTrials.gov:NCT0...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید